Within the inflamed intestinal mucosa of IBD patients, dysregulated expression of NF-κB precursors, NF-κB itself, and immune receptors stimulated by NF-κB (such as NOD2 [nucleotide-binding oligomerization domain-containing protein 2]) has been observed. Here, NFKB1 is linked to inflammatory bowel disease.